These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16145414)

  • 41. A Randomized, Open-Label, Comparative Study of Efficacy and Safety of Tolterodine Combined with Tamsulosin or Doxazosin in Patients with Benign Prostatic Hyperplasia.
    Cao Y; Wang Y; Guo L; Yang X; Chen T; Niu H
    Med Sci Monit; 2016 Jun; 22():1895-902. PubMed ID: 27260129
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of propiverine ER with or without α-blockers related to maximum urinary flow rate in adult men with OAB: results of a 12-week, multicenter, non-interventional study.
    Oelke M; Murgas S; Baumann I; Schnabel F; Michel MC
    World J Urol; 2011 Apr; 29(2):217-23. PubMed ID: 21327673
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of extended-release doxazosin and doxazosin standard in patients with concomitant benign prostatic hyperplasia and sexual dysfunction.
    Kirby RS; O'Leary MP; Carson C
    BJU Int; 2005 Jan; 95(1):103-9; discussion 109. PubMed ID: 15638905
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review.
    Kaplan SA; Roehrborn CG; Abrams P; Chapple CR; Bavendam T; Guan Z
    Int J Clin Pract; 2011 Apr; 65(4):487-507. PubMed ID: 21210910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: a randomized controlled trial.
    Kaplan SA; He W; Koltun WD; Cummings J; Schneider T; Fakhoury A
    Eur Urol; 2013 Jan; 63(1):158-65. PubMed ID: 22831853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. alpha1-Adrenergic blockers in young men with primary bladder neck obstruction.
    Yang SS; Wang CC; Hsieh CH; Chen YT
    J Urol; 2002 Aug; 168(2):571-4. PubMed ID: 12131312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combination therapy with doxazosin and tenoxicam for the management of lower urinary tract symptoms.
    Ozdemir I; Bozkurt O; Demir O; Aslan G; Esen AA
    Urology; 2009 Aug; 74(2):431-5. PubMed ID: 19501883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in overactive bladder symptoms after discontinuation of successful 3-month treatment with an antimuscarinic agent: a prospective trial.
    Choo MS; Song C; Kim JH; Choi JB; Lee JY; Chung BS; Lee KS
    J Urol; 2005 Jul; 174(1):201-4. PubMed ID: 15947627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of doxazosin in the treatment of acute urinary retention due to benign prostate hyperplasia.
    Prieto L; Romero J; López C; Ortiz M; Pacheco JJ
    Urol Int; 2008; 81(1):66-71. PubMed ID: 18645274
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
    Wagg A; Wyndaele JJ; Sieber P
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
    Yang Y; Zhao XF; Li HZ; Wang W; Zhang Y; Xiao H; Zhang X
    Chin Med J (Engl); 2007 Mar; 120(5):370-4. PubMed ID: 17376305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Persistence with solifenacin add-on therapy in men with benign prostate obstruction and residual symptoms of overactive bladder after tamsulosin monotherapy.
    Lee YS; Lee KS; Kim JC; Hong S; Chung BH; Kim CS; Lee JG; Kim DK; Park CH; Park JK
    Int J Clin Pract; 2014 Dec; 68(12):1496-502. PubMed ID: 25284747
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of the doxazosin gastrointestinal therapeutic system for the treatment of benign prostate hyperplasia.
    Sun GH; Tsui KH; Wu TT; Chang CH; Cheng CL; Schou M
    Kaohsiung J Med Sci; 2010 Oct; 26(10):532-9. PubMed ID: 20950778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study.
    Athanasopoulos A; Gyftopoulos K; Giannitsas K; Fisfis J; Perimenis P; Barbalias G
    J Urol; 2003 Jun; 169(6):2253-6. PubMed ID: 12771763
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Additional correction of OAB symptoms by two anti-muscarinics for men over 50 years old with residual symptoms of moderate prostatic obstruction after treatment with Tamsulosin.
    Kosilov K; Loparev S; Ivanovskaya M; Kosilova L
    Aging Male; 2015 Mar; 18(1):44-8. PubMed ID: 25136746
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of alfuzosin 10 mg with or without propiverine 10 mg, 20 mg in men with lower urinary tract symptom and an overactive bladder: randomised, single-blind, prospective study.
    Cho HJ; Shin SC; Seo DY; Cho JM; Kang JY; Yoo TK; Yu JH; Sung LH; Moon HS
    Int J Clin Pract; 2014 Apr; 68(4):471-7. PubMed ID: 24471868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Progression of lower urinary tract symptoms after discontinuation of 1 medication from 2-year combined alpha-blocker and 5-alpha-reductase inhibitor therapy for benign prostatic hyperplasia in men--a randomized multicenter study.
    Lin VC; Liao CH; Kuo HC
    Urology; 2014 Feb; 83(2):416-21. PubMed ID: 24332123
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apoptotic regression of prostatic tissue induced by short-term doxazosin treatment in benign prostatic hyperplasia.
    Türkeri LN; Ozyürek M; Ersev D; Akdaş A
    Arch Esp Urol; 2001 Mar; 54(2):191-6. PubMed ID: 11341128
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Doxazosin gastrointestinal therapeutic system: a review of its use in benign prostatic hyperplasia.
    Goldsmith DR; Plosker GL
    Drugs; 2005; 65(14):2037-47. PubMed ID: 16162024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Does alpha1-blocker provide additional improvement of quality-of-life in patients with overactive bladder?--a multi-center prospective randomized trial between anti-cholinergic (propiverine chloride) with and without alpha1-blocker (urapidil)].
    Matsuyama H; Shimizu Y; Kamiryo Y; Joko K; Shimabukuro T; Suga A; Takemoto M; Imoto K; Hara Y; Yamamoto N; Kaneda Y; Harada N; Naito K
    Nihon Hinyokika Gakkai Zasshi; 2007 May; 98(4):604-13. PubMed ID: 17564103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.